News
01-18-2011, 04:20 AM
A new study by Ohio State University cancer researchers provides a rational for treating breast cancer by combining two kinds of targeted agents, one that inhibits an overactive, cancer-causing pathway in cancer cells and one that reverses changes that silence genes that normally prevent cancer...
More... (http://mnt.to/f/3Q6q)
More... (http://mnt.to/f/3Q6q)